JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4077 Dabigatran

Summary: A potent, reversible direct thrombin inhibitor with core bioactivity of inhibiting thrombus formation.

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A4157 Iniparib (BSI-201)

Summary: PARP1 inhibitor,intravenously adminsitered

insoluble in H2O; ≥103.4 mg/mL
A2606 Epoxomicin
35 Citation

Summary: proteasome inhibitor

≥27.73 mg/mL
A4038 Alogliptin (SYR-322)
1 Citation

Target: DPP-4

Summary: DPP-4 inhibitor,potent and highly selective
A4114 MLN8054

Target: Aurora Kinases

Summary: Aurora A inhibitor

insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
A4211 Lenalidomide (CC-5013)

Target: angiogenesis

Summary: Antineoplastic agent,inhibits angiogenesis

insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
A4206 Pifithrin-α (PFTα)
6 Citation

Target: p53

Summary: p53 inhibitor

insoluble in H2O; ≥17.45 mg/mL
A4170 EPZ004777

Target: DOT1L

Summary: DOT1L inhibitor

≥27 mg/mL
A4302 Rosiglitazone maleate

Target: Insulin and Insulin-like Receptors

Summary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer

≥23.7 mg/mL
A4321 Sildenafil Citrate

Target: Phosphodiesterases (PDEs)

Summary: Treat erectile dysfunction and PAH

≥25.35 mg/mL